Related Experiment Video
Updated: Oct 5, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Extended Oral Antibiotics Increase Bacterial Resistance in Patients Who Fail 2-Stage Exchange for Periprosthetic
Mick P Kelly1, Jeremy M Gililland1, Brenna E Blackburn1
1Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT.
Background:
Although studies have demonstrated reductions in recurrent periprosthetic joint infection (PJI) with the administration of prolonged oral antibiotics at second-stage reimplantation, the potential for increasing bacterial resistance has not been studied. The purpose of this study was to determine if oral antibiotics at second-stage reimplantation increased the rate of antibiotic resistance in subsequent infections.
Methods:
We retrospectively reviewed patients who underwent 2-stage exchange for chronic PJI from 2014 to 2019. We compared those who had received prolonged oral antibiotics at the time of stage 2 reimplantation with those who did not. The primary outcome was the presence of resistant organisms in any subsequent infection. The secondary outcome was the overall rate of recurrent PJI in the 2 groups. Multivariable analyses controlling for demographics and comorbid conditions were used.
Results:
Of the 211 patients who underwent 2-stage exchange for PJI, 158 patients received prolonged oral antibiotics. The mean follow-up was 2.2 years. Recurrent PJI was diagnosed in 24 of 158 (15%) patients who received oral antibiotics compared with 11 of 53 (21%) patients who did not receive antibiotics (P = .35). PJI with resistant organisms was identified in 16 of 24 (67%) patients who received antibiotics compared with 0 of 11 (0%) patients who did not receive antibiotics (P = .0001).
Conclusions:
Prolonged oral antibiotics following 2-stage exchange increase drug resistance to that antibiotic in subsequent PJI. We recommend further research in the area to refine antimicrobial protocols as we consider the risks and benefits of prolonged antibiotic treatment.
Insights
Prolonged oral antibiotics after periprosthetic joint infection (PJI) treatment may increase antibiotic resistance in subsequent infections. This study found a significantly higher rate of resistant organisms in patients who received oral antibiotics during reimplantation.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Recurrent periprosthetic joint infection (PJI) management often involves two-stage reimplantation.
- Prolonged oral antibiotic administration is used to reduce recurrent PJI rates.
- The impact of these antibiotics on subsequent bacterial resistance is not well understood.
Purpose of the Study:
- To investigate whether prolonged oral antibiotics at second-stage reimplantation for PJI increase the rate of antibiotic resistance in subsequent infections.
Main Methods:
- Retrospective review of patients undergoing two-stage exchange for chronic PJI (2014-2019).
- Comparison of outcomes between patients receiving prolonged oral antibiotics at stage 2 reimplantation versus those who did not.
- Primary outcome: presence of resistant organisms in subsequent infections; Secondary outcome: recurrent PJI rates. Multivariable analyses were performed.
Main Results:
- Of 211 patients, 158 received prolonged oral antibiotics.
- Recurrent PJI rates were similar: 15% with antibiotics vs. 21% without (P = .35).
- PJI with resistant organisms was significantly higher in the antibiotic group (67% vs. 0%, P = .0001).
Conclusions:
- Prolonged oral antibiotic use following two-stage exchange for PJI is associated with increased drug resistance in subsequent infections.
- Further research is needed to optimize antimicrobial protocols considering the risks and benefits.
- Antimicrobial stewardship is crucial in managing PJI to mitigate resistance development.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antibiotic Selection
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

